Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ortiz OS"'
Autor:
Ortiz Ospina, Esteban
This DPhil thesis consists of three related but independent chapters discussing the question of admission and access to higher education. Chapter 1 explores the extent to which the underrepresentation of students from certain population groups at hig
Externí odkaz:
http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711961
Autor:
Kreitman RJ; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Yu T; Office of Research Nursing, National Cancer Institute, National Institutes of Health, Bethesda, MD., James L; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Feurtado J; Office of Research Nursing, National Cancer Institute, National Institutes of Health, Bethesda, MD., Eager H; Office of Research Nursing, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ortiz OS; Office of Research Nursing, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gould M; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Mauter J; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Zhou H; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Burbelo PD; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD., Cohen JI; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Wang HW; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Yuan CM; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD., Arons E; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Publikováno v:
Blood advances [Blood Adv] 2023 Dec 12; Vol. 7 (23), pp. 7161-7168.
Autor:
Girardi DM; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Niglio SA; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, Ohio., Nadal R; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lara P; University of California Davis Comprehensive Cancer Center, Sacramento, California., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California., Saraiya B; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Cordes L; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ley L; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ortiz OS; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Cadena J; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Diaz C; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Bagheri H; Clinical Image Processing Service, Department of Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, Maryland., Redd B; Clinical Image Processing Service, Department of Radiology and Imaging Sciences, Clinical Center, NIH, Bethesda, Maryland., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Chan KS; Samuel Oschin Cancer Center, Cedars Sinai Medical Center, Los Angeles, California., Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lee S; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Yu Y; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Gurram S; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Chalfin HJ; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Valera V; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Merino M; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Toubaji A; Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Streicher H; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Wright JJ; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Sharon E; Investigational Drug Branch, Cancer Therapy Evaluation Program, NCI, NIH, Rockville, Maryland., Parnes HL; Division of Cancer Prevention, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Ning YM; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Cao L; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Trepel JB; Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 01; Vol. 28 (7), pp. 1353-1362.